Endpoints News 生物医药· Anna Brown·· 17 天前AI 评分31
WuXi Biologics 和 Fresenius 达成大型生物类似药合作
WuXi Biologics, Fresenius partner ahead of biosimilar boom
AI 导读
WuXi Biologics 和德国制药商 Fresenius 近达成一项大型生物类似药合作协议,预示着生物类似药市场的蓬勃发展。
正文
WuXi Biologics and German drugmaker Fresenius have reached one of the largest biosimilar deals to date ahead of what some in the industry have called …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news